CRO

Charles River reopening preclinical site; Illumina dives into consumer genomics;

> Charles River Laboratories ($CRL) is planning to reopen a preclinical research outpost it closed in 2010, citing an increase in demand for early-stage services. News

> Sequencing giant Illumina ($ILMN) recruited Warburg Pincus, the Mayo Clinic and Sutter Hill Ventures to launch Helix, a consumer genomics company setting sail with $100 million from its founders. More